Fig. 8From: FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cellsResidual cisplatin concentration in three groups treated by the same reference concentration after 48 h (a).*,P < 0.05,compared with the two control groups. Curve of residual cisplatin concentration in three groups treated by the same reference concentration after 48 h (b). Control group: SKOV3,Empty vector group: pWPI-SKO3,Experimental group: pWPI-FOLR1-SKOV3Back to article page